Common Contracts

2 similar Underwriting Agreement contracts by Elmet Group Co., Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. 6,500,000 Shares of Common Stock, Par Value $0.0001 UNDERWRITING AGREEMENT
Underwriting Agreement • April 16th, 2026 • Spyre Therapeutics, Inc. • Pharmaceutical preparations • New York
THE ELMET GROUP CO. [●] Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreement • April 14th, 2026 • Elmet Group Co. • Miscellaneous fabricated metal products • New York

The Elmet Group Co., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [●] shares of its common stock, par value $0.001 per share (the “Shares”). The [●] Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters a 30-day option to purchase up to an additional [●] Shares (the “Over-Allotment Option”). The additional [●] Shares to be sold by the Company pursuant to the Over-Allotment Option are collectively called the “Over-Allotment Option Shares.” The Firm Shares and, if and to the extent the Over-Allotment Option is exercised, the Over-Allotment Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent ther